קטגוריה:Therapeutic subgroup

×¨×× ×©× ××× ×©× ×§×× ATC â ×§×××¦× ×ª×¨×¤×××××ª

×§××××¨×××ª ××©× ×

××£ ×§××××¨×× ×× ×××× ××ª 94 ×§××××¨×××ª ×××©× × ×××××ª, ××ª×× 94 ××§××××¨×× ××××.

A

Agents acting on the renin-angiotensin system - C09â (5 ×§×', 112 ××¤××)
All other non-therapeutic products - V07â (×§×' ×××ª)
All other therapeutic products - V03â (×§×' ×××ª, 82 ××¤××)
Allergens - V01â (×§×' ×××ª, 9 ××¤××)
Anabolic agents for systemic use - A14â (2 ×§×')
Analgesics - N02â (3 ×§×', 270 ××¤××)
Anesthetics - N01â (2 ×§×', 145 ××¤××)
Anthelmintics - P02â (3 ×§×', 3 ××¤××)
Anti-acne preparations - D10â (2 ×§×', 47 ××¤××)
Anti-inflammatory and antirheumatic products - M01â (3 ×§×', 102 ××¤××)
Anti-parkinson drugs - N04â (2 ×§×', 65 ××¤××)
Antianemic preparations - B03â (3 ×§×', 88 ××¤××)
Antibacterials for systemic use - J01â (10 ×§×', 261 ××¤××)
Antibiotics and chemotherapeutics for dermatological use - D06â (3 ×§×', 38 ××¤××)
Antidiarrheals, intestinal anti-inflammatory/anti-infective agents - A07â (7 ×§×', 69 ××¤××)
Antiemetics and antinauseants - A04â (×§×' ×××ª, 28 ××¤××)
Antiepileptics - N03â (×§×' ×××ª, 128 ××¤××)
Antifungals for dermatological use - D01â (2 ×§×', 78 ××¤××)
Antigout preparations - M04â (×§×' ×××ª, 4 ××¤××)
Antihemorrhagics - B02â (2 ×§×', 133 ××¤××)
Antihistamines for systemic use - R06â (×§×' ×××ª, 64 ××¤××)
Antihypertensives - C02â (7 ×§×', 42 ××¤××)
Antimycobacterials - J04â (2 ×§×', 2 ××¤××)
Antimycotics for systemic use - J02â (×§×' ×××ª, 69 ××¤××)
Antineoplastic agents - L01â (7 ×§×', 597 ××¤××)
Antiobesity preparations, excluding diet products - A08â (×§×' ×××ª, 6 ××¤××)
Antiprotozoals - P01â (3 ×§×', 14 ××¤××)
Antipruritics, including antihistamines, anesthetics, etc - D04â (×§×' ×××ª, 25 ××¤××)
Antipsoriatics - D05â (2 ×§×', 18 ××¤××)
Antiseptics and disinfectants - D08â (×§×' ×××ª, 51 ××¤××)
Antithrombotic agents - B01â (×§×' ×××ª, 194 ××¤××)
Antivirals for systemic use - J05â (×§×' ×××ª, 147 ××¤××)

A (×××©×)

Appetite stimulants - A15â (×¨××§×)

B

Beta blocking agents - C07â (6 ×§×', 41 ××¤××)
Bile and liver therapy - A05â (3 ×§×', 16 ××¤××)
Blood substitutes and perfusion solutions - B05â (6 ×§×', 182 ××¤××)

C

Calcium channel blockers - C08â (4 ×§×', 63 ××¤××)
Calcium homeostasis - H05â (2 ×§×', 29 ××¤××)
Cardiac therapy - C01â (5 ×§×', 92 ××¤××)
Contrast media - V08â (4 ×§×', 37 ××¤××)
Corticosteroids for systemic use - H02â (3 ×§×', 44 ××¤××)
Corticosteroids, dermatological preparations - D07â (4 ×§×', 53 ××¤××)
Cough and cold preparations - R05â (4 ×§×', 52 ××¤××)

D

Diagnostic agents - V04â (2 ×§×', 8 ××¤××)
Diagnostic radiopharmaceuticals - V09â (10 ×§×', 14 ××¤××)
Digestives,including enzymes - A09â (×§×' ×××ª, 7 ××¤××)
Diuretics - C03â (6 ×§×', 30 ××¤××)
Drugs for acid related disorders - A02â (3 ×§×', 88 ××¤××)
Drugs for constipation - A06â (×§×' ×××ª, 42 ××¤××)
Drugs for functional gastrointestinal disorders - A03â (6 ×§×', 31 ××¤××)
Drugs for obstructive airway diseases - R03â (4 ×§×', 116 ××¤××)
Drugs for treatment of bone diseases - M05â (×§×' ×××ª, 45 ××¤××)
Drugs used in diabetes - A10â (3 ×§×', 219 ××¤××)

E

Ectoparasiticides, including scabicides, insecticides and repellents - P03â (2 ×§×', 4 ××¤××)
Emollients and protectives - D02â (2 ×§×', 4 ××¤××)
Endocrine therapy - L02â (2 ×§×', 88 ××¤××)

G

General nutrients - V06â (4 ×§×', 12 ××¤××)
Gynecological antiinfectives and antiseptics - G01â (2 ×§×', 22 ××¤××)

I

Immune sera and immunoglobulins - J06â (2 ×§×', 45 ××¤××)
Immunostimulants - L03â (×§×' ×××ª, 50 ××¤××)
Immunosuppressants - L04â (2 ×§×', 274 ××¤××)

L

Lipid modifying agents - C10â (2 ×§×', 146 ××¤××)

M

Medicated dressings - D09â (×§×' ×××ª, 8 ××¤××)
Mineral supplements - A12â (3 ×§×', 42 ××¤××)

M (×××©×)

Muscle relaxants - M03â (3 ×§×', 29 ××¤××)

N

Nasal preparations - R01â (2 ×§×', 100 ××¤××)

O

Ophthalmological and otological preparations - S03â (4 ×§×', 8 ××¤××)
Ophthalmologicals - S01â (11 ×§×', 179 ××¤××)
Other alimentary tract and metabolism products - A16â (×§×' ×××ª, 47 ××¤××)
Other dermatological preparations - D11â (×§×' ×××ª, 30 ××¤××)
Other drugs for disorders of the musculo-skeletal system - M09â (×§×' ×××ª, 5 ××¤××)
Other gynecologicals - G02â (3 ×§×', 29 ××¤××)
Other hematological agents - B06â (×§×' ×××ª, 13 ××¤××)
Other nervous system drugs - N07â (4 ×§×', 68 ××¤××)
Other respiratory system products - R07â (×§×' ×××ª, 15 ××¤××)
Otologicals - S02â (4 ×§×', 9 ××¤××)

P

Pancreatic hormones - H04â (×§×' ×××ª, 2 ××¤××)
Peripheral vasodilators - C04â (×§×' ×××ª, 7 ××¤××)
Pituitary and hypothalamic hormones and analogues - H01â (3 ×§×', 89 ××¤××)
Preparations for treatment of wounds and ulcers - D03â (2 ×§×', 3 ××¤××)
Psychoanaleptics - N06â (4 ×§×', 276 ××¤××)
Psycholeptics - N05â (3 ×§×', 251 ××¤××)

S

Sex hormones and modulators of the genital system - G03â (9 ×§×', 130 ××¤××)
Stomatological preparations - A01â (×§×' ×××ª, 22 ××¤××)
Surgical dressings - V20â (×¨××§×)

T

Therapeutic radiopharmaceuticals - V10â (3 ×§×', 7 ××¤××)
Throat preparations - R02â (×§×' ×××ª, 31 ××¤××)
Thyroid therapy - H03â (3 ×§×', 9 ××¤××)
Tonics - A13â (×§×' ×××ª)
Topical products for joint and muscular pain - M02â (×§×' ×××ª, 45 ××¤××)

U

Urologicals - G04â (2 ×§×', 122 ××¤××)

V

Vaccines - J07â (4 ×§×', 85 ××¤××)
Vasoprotectives - C05â (3 ×§×', 17 ××¤××)
Vitamins - A11â (8 ×§×', 27 ××¤××)

השינוי האחרון נעשה בֹ־27 בדצמבר 2013 ב־09:33